HC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $12 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Yi Chen has reiterated a Buy rating on Anixa Biosciences (NASDAQ:ANIX) and maintained a $12 price target.
May 23, 2023 | 10:17 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst Yi Chen reiterated a Buy rating on Anixa Biosciences and maintained a $12 price target.
The reiteration of a Buy rating and maintenance of a $12 price target by HC Wainwright & Co. analyst Yi Chen indicates a positive outlook for Anixa Biosciences. This news is likely to have a positive impact on the stock price in the short term as it shows confidence in the company's potential.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100